2025 annual financial data
Cellyan Biotechnology 2025 Operating margin
Direct answer
Operating margin was 0.65%.
Operating income was 132,038 USD and net income was -27,056 USD.
Operating cash flow was 569,214 USD.
Get free Cellyan Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 20,313,818 USD
- Operating income
- 132,038 USD
- Net income
- -27,056 USD
- Operating cash flow
- 569,214 USD